Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
- PMID: 30379613
- PMCID: PMC6464372
- DOI: 10.1056/NEJMoa1804923
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Abstract
Background: Minimally invasive surgery was adopted as an alternative to laparotomy (open surgery) for radical hysterectomy in patients with early-stage cervical cancer before high-quality evidence regarding its effect on survival was available. We sought to determine the effect of minimally invasive surgery on all-cause mortality among women undergoing radical hysterectomy for cervical cancer.
Methods: We performed a cohort study involving women who underwent radical hysterectomy for stage IA2 or IB1 cervical cancer during the 2010-2013 period at Commission on Cancer-accredited hospitals in the United States. The study used inverse probability of treatment propensity-score weighting. We also conducted an interrupted time-series analysis involving women who underwent radical hysterectomy for cervical cancer during the 2000-2010 period, using the Surveillance, Epidemiology, and End Results program database.
Results: In the primary analysis, 1225 of 2461 women (49.8%) underwent minimally invasive surgery. Women treated with minimally invasive surgery were more often white, privately insured, and from ZIP Codes with higher socioeconomic status, had smaller, lower-grade tumors, and were more likely to have received a diagnosis later in the study period than women who underwent open surgery. Over a median follow-up of 45 months, the 4-year mortality was 9.1% among women who underwent minimally invasive surgery and 5.3% among those who underwent open surgery (hazard ratio, 1.65; 95% confidence interval [CI], 1.22 to 2.22; P=0.002 by the log-rank test). Before the adoption of minimally invasive radical hysterectomy (i.e., in the 2000-2006 period), the 4-year relative survival rate among women who underwent radical hysterectomy for cervical cancer remained stable (annual percentage change, 0.3%; 95% CI, -0.1 to 0.6). The adoption of minimally invasive surgery coincided with a decline in the 4-year relative survival rate of 0.8% (95% CI, 0.3 to 1.4) per year after 2006 (P=0.01 for change of trend).
Conclusions: In an epidemiologic study, minimally invasive radical hysterectomy was associated with shorter overall survival than open surgery among women with stage IA2 or IB1 cervical carcinoma. (Funded by the National Cancer Institute and others.).
Figures
Comment in
-
Survival of women with early-stage cervical cancer in the UK treated with minimal access and open surgery.BJOG. 2019 Jul;126(8):956-959. doi: 10.1111/1471-0528.15617. Epub 2019 Mar 1. BJOG. 2019. PMID: 30658010 No abstract available.
-
[Impact of surgical approach on prognosis in early-stage cervical cancer].Strahlenther Onkol. 2019 Mar;195(3):274-276. doi: 10.1007/s00066-019-01426-9. Strahlenther Onkol. 2019. PMID: 30689029 German. No abstract available.
-
Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.N Engl J Med. 2019 Feb 21;380(8):793. doi: 10.1056/NEJMc1816590. N Engl J Med. 2019. PMID: 30786197 No abstract available.
-
Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.N Engl J Med. 2019 Feb 21;380(8):793-4. doi: 10.1056/NEJMc1816590. N Engl J Med. 2019. PMID: 30789679 No abstract available.
-
Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.N Engl J Med. 2019 Feb 21;380(8):794. doi: 10.1056/NEJMc1816590. N Engl J Med. 2019. PMID: 30789680 No abstract available.
-
Reconsider minimally invasive surgery for early cervical cancer.Ann Transl Med. 2019 Jul;7(Suppl 3):S111. doi: 10.21037/atm.2019.05.25. Ann Transl Med. 2019. PMID: 31576318 Free PMC article. No abstract available.
-
Unexpected results from randomized clinical trials. Or are they?Fertil Steril. 2019 Nov;112(5):804-805. doi: 10.1016/j.fertnstert.2019.08.055. Fertil Steril. 2019. PMID: 31731935 No abstract available.
References
-
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cervical cancer, version 1.2018. (http://oncolife.com.ua/doc/nccn/Cervical_Cancer.pdf). - PubMed
-
- Colombo N, Carinelli S, Colombo A, Marini C, Rollo D, Sessa C. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23:Suppl 7:vii27–vii32. - PubMed
-
- Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol 2009;201(5):485.e1–9. - PubMed
-
- Peters WA III, Liu PY, Barrett RJ II, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606–13. - PubMed